Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

3 Neil Woodford High-Yield Picks: GlaxoSmithKline plc, NEXT plc And Legal & General Group Plc

GlaxoSmithKline plc (LON:GSK), NEXT plc (LON:NXT) and Legal & General Group Plc (LON:LGEN) are Woodford’s heavyweight high-yield picks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Top fund manager Neil Woodford is not one for chasing high yields that subsequently prove unsustainable. He was out of banks well before the credit crunch smashed payouts in the sector, and he’s dodged the current round of slashed dividends in the mining industry.

But he does hold some stocks that offer yields well above the market average. His FTSE 100 heavyweights with the highest payouts are GlaxoSmithKline (LSE: GSK), Next (LSE: NXT) and Legal & General (LSE: LGEN).

Pharma favourite

Glaxo is set to return to earnings growth in 2016 after a number of difficult years. In its results for 2015, released earlier this month, the company reported a decline in core earnings of 15% (at constant exchange rates). This was actually a little better than guidance, but even more welcome was management’s expectation of double-digit growth in 2016.

The integration of new businesses in Vaccines and Consumer Healthcare, the restructuring of the Global Pharmaceuticals division and the acceleration of new product sales should all drive earnings upwards in coming years. In fact, new product sales are now expected to reach management’s £6bn target up to two years earlier than previously guided (2018, rather than 2020).

The board has reiterated its intention to pay a flat 80p dividend for 2016 and 2017, giving an annual yield of 5.8% at a recent share price of 1,386p. With dividend cover improving as earnings growth kicks in, payouts should then be able to resume a healthy upwards trajectory.

Fashion focus

High street stalwart Next has yet to release results for its financial year ended 30 January, but has provided a trading update. The company said an unseasonably warm November and December would drag full-year sales down to just below the bottom end of previous guidance, but that profit was still on track thanks to good control of margins, costs and stock.

The company has paid out 153p of ordinary dividends during the fiscal year and 230p of special dividends, giving a total running yield of 5.7% at a recent share price of 6,750p. Special dividends (and share buybacks) are an ongoing feature of Next’s focus on delivering value to shareholders. And an increase in payouts is forecast for the year to January 2017, lifting the yield to 6%.

Insurance income

Analysts expect Legal & General to declare a final dividend of 9.9p when it announces its annual results on 15 March. Added to the last interim payout of 3.45p, this gives 13.35p, and a yield of 6.1% at a recent share price of 218p. Expected growth drives the forecast yield for 2016 up to 6.5%.

Something of a changing of the guard is underway at Legal & General, with separate announcements of the retirement of both the chairman and finance director having been made in recent months. Investors have also been a little unnerved by L&G’s potential exposure to bonds in the troubled oil and mining sectors. However, the company detailed its limited exposure to these sectors earlier this month.

Woodford and his team remain “very positive on the prospect of consistent and attractive long-term dividend growth”.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The BP share price could face a brutal reckoning in 2026

Harvey Jones is worried about the outlook for the BP share price, as the global economy struggles and experts warn…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

How on earth did Lloyds shares explode 75% in 2025?

Harvey Jones has been pleasantly surprised by the blistering performance of Lloyds shares over the last year or two. Will…

Read more »

Group of four young adults toasting with Flying Horse cans in Brazil
Investing Articles

Down 56% with a 4.8% yield and P/E of 13 – are Diageo shares a generational bargain?

When Harvey Jones bought Diageo shares he never dreamed they'd perform this badly. Now he's wondering if they're just too…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Could these 3 holdings in my Stocks and Shares ISA really increase in value by 25% in 2026?

James Beard’s been looking at the 12-month share price forecasts for some of the positions in his Stocks and Shares…

Read more »

National Grid engineers at a substation
Investing Articles

2 reasons I‘m not touching National Grid shares with a bargepole!

Many private investors like the passive income prospects they see in National Grid shares. So why does our writer not…

Read more »

Number 5 foil balloon and gold confetti on black.
Investing Articles

£10,000 invested in Greggs shares 5 years ago would have generated this much in dividends…

Those who invested in Greggs shares five years ago have seen little share price growth. However, the dividends have been…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Growth Shares

Here is the Rolls-Royce share price performance for 2023, 2024, and 2025

Where will the Rolls-Royce share price be at the end of 2026? Looking at previous years might help us find…

Read more »

Investing Articles

This FTSE 250 stock could rocket 49%, say brokers

Ben McPoland takes a closer look at a market-leading FTSE 250 company that generates plenty of cash and has begun…

Read more »